Junwei Fang

784 total citations
44 papers, 593 citations indexed

About

Junwei Fang is a scholar working on Molecular Biology, Ophthalmology and Complementary and alternative medicine. According to data from OpenAlex, Junwei Fang has authored 44 papers receiving a total of 593 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 14 papers in Ophthalmology and 7 papers in Complementary and alternative medicine. Recurrent topics in Junwei Fang's work include Metabolomics and Mass Spectrometry Studies (15 papers), Retinal Diseases and Treatments (13 papers) and Traditional Chinese Medicine Studies (7 papers). Junwei Fang is often cited by papers focused on Metabolomics and Mass Spectrometry Studies (15 papers), Retinal Diseases and Treatments (13 papers) and Traditional Chinese Medicine Studies (7 papers). Junwei Fang collaborates with scholars based in China, United States and Hong Kong. Junwei Fang's co-authors include Kun Liu, Yongyu Zhang, Shujun Sun, Hanying Wang, Huijuan Cao, Xiaoyin Xu, Shuhai Lin, Ningning Zheng, Haiyan Wang and Fenge Chen and has published in prestigious journals such as Diabetes, Annals of Oncology and Journal of Ethnopharmacology.

In The Last Decade

Junwei Fang

40 papers receiving 585 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junwei Fang China 14 278 179 111 87 76 44 593
Ming Jin China 14 201 0.7× 209 1.2× 52 0.5× 119 1.4× 70 0.9× 48 596
Di Yang China 13 194 0.7× 156 0.9× 97 0.9× 91 1.0× 53 0.7× 52 727
Aicha Saadane United States 18 424 1.5× 257 1.4× 51 0.5× 79 0.9× 13 0.2× 32 921
Xiujuan Zhao China 17 252 0.9× 431 2.4× 218 2.0× 378 4.3× 38 0.5× 79 890
Wen Zeng China 14 142 0.5× 31 0.2× 64 0.6× 72 0.8× 27 0.4× 49 501
Fen Tang China 13 158 0.6× 121 0.7× 41 0.4× 95 1.1× 6 0.1× 50 608

Countries citing papers authored by Junwei Fang

Since Specialization
Citations

This map shows the geographic impact of Junwei Fang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junwei Fang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junwei Fang more than expected).

Fields of papers citing papers by Junwei Fang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junwei Fang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junwei Fang. The network helps show where Junwei Fang may publish in the future.

Co-authorship network of co-authors of Junwei Fang

This figure shows the co-authorship network connecting the top 25 collaborators of Junwei Fang. A scholar is included among the top collaborators of Junwei Fang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junwei Fang. Junwei Fang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Qu, Yuan, Yujuan Liu, Junwei Fang, et al.. (2025). Dysregulated serum lipid profiles in neovascular age-related macular degeneration revealed by UPLC‒MS/MS lipidomics. Lipids in Health and Disease. 24(1). 302–302. 1 indexed citations
2.
Wang, Liping, Ran Zhou, Guanghui Li, et al.. (2025). Multi-omics characterization of diabetic nephropathy in the db/db mouse model of type 2 diabetes. Computational and Structural Biotechnology Journal. 27. 3399–3409.
3.
Fang, Junwei, Xin Shi, Yanfeng Jiang, et al.. (2025). Mass spectrometry-based metabolomic and lipidomic profiling stratifies stages of diabetic retinopathy. Diabetes Research and Clinical Practice. 228. 112423–112423.
5.
Wang, Yihan, Yujuan Liu, Junwei Fang, et al.. (2024). Small-molecule agonist AdipoRon alleviates diabetic retinopathy through the AdipoR1/AMPK/EGR4 pathway. Journal of Translational Medicine. 22(1). 2–2. 9 indexed citations
6.
Yi, Ying, et al.. (2024). Sertraline-Induced Acute Pancreatitis: A Case Report and Literature Review.. PubMed. 30(10). 318–321. 3 indexed citations
7.
Shen, Yinchen, Hanying Wang, Junwei Fang, Kun Liu, & Xun Xu. (2023). Novel insights into the mechanisms of hard exudate in diabetic retinopathy: Findings of serum lipidomic and metabolomics profiling. Heliyon. 9(4). e15123–e15123. 15 indexed citations
8.
Wang, Yihan, Junwei Fang, Hanying Wang, et al.. (2022). Serum Ang-1/Ang-2 ratio may be a promising biomarker for evaluating severity of diabetic retinopathy. Graefe s Archive for Clinical and Experimental Ophthalmology. 261(1). 49–55. 9 indexed citations
10.
Wang, Hanying, Xiaoyin Xu, Chong Chen, et al.. (2022). Metabolomics study of treatment response to conbercept of patients with neovascular age-related macular degeneration and polypoidal choroidal vasculopathy. Frontiers in Pharmacology. 13. 991879–991879. 6 indexed citations
11.
Shi, Xin, Shaopin Zhu, Huiyi Jin, et al.. (2021). The Anti-Inflammatory Effect of KS23, A Novel Peptide Derived From Globular Adiponectin, on Endotoxin-Induced Uveitis in Rats. Frontiers in Pharmacology. 11. 585446–585446. 10 indexed citations
12.
Liu, Kun, Junwei Fang, Jin Jing, et al.. (2019). Serum Metabolomics Reveals Personalized Metabolic Patterns for Macular Neovascular Disease Patient Stratification. Journal of Proteome Research. 19(2). 699–707. 21 indexed citations
13.
Wang, Haiyan, et al.. (2019). Metabolomic Profile of Posner–Schlossman Syndrome: A Gas Chromatography Time-of-Flight Mass Spectrometry-Based Approach Using Aqueous Humor. Frontiers in Pharmacology. 10. 1322–1322. 12 indexed citations
14.
Wang, Haiyan, Junwei Fang, Fenge Chen, et al.. (2019). Metabolomic profile of diabetic retinopathy: a GC-TOFMS-based approach using vitreous and aqueous humor. Acta Diabetologica. 57(1). 41–51. 65 indexed citations
15.
Fang, Junwei, Liping Wang, Yang Wang, Mingfeng Qiu, & Yongyu Zhang. (2017). Metabolomics combined with pattern recognition and bioinformatics analysis methods for the development of pharmacodynamic biomarkers on liver fibrosis. Molecular BioSystems. 13(8). 1575–1583. 6 indexed citations
16.
Fang, Junwei, Wenyu Wang, Shujun Sun, et al.. (2016). Metabolomics study of renal fibrosis and intervention effects of total aglycone extracts of Scutellaria baicalensis in unilateral ureteral obstruction rats. Journal of Ethnopharmacology. 192. 20–29. 18 indexed citations
17.
Wang, Yang, Huijuan Cao, Shujun Sun, et al.. (2016). Total flavonoid aglycones extract in Radix scutellariae inhibits lung carcinoma and lung metastasis by affecting cell cycle and DNA synthesis. Journal of Ethnopharmacology. 194. 269–279. 18 indexed citations
18.
Fang, Junwei, Wenyu Wang, Shujun Sun, et al.. (2015). A urine metabonomics study of chronic renal failure and intervention effects of total aglycone extracts of Scutellaria baicalensis in 5/6 nephrectomy rats. RSC Advances. 5(92). 75612–75621. 10 indexed citations
19.
Dai, Jianye, Junwei Fang, Shujun Sun, et al.. (2013). ZHENG-Omics Application in ZHENG Classification and Treatment: Chinese Personalized Medicine. Evidence-based Complementary and Alternative Medicine. 2013. 1–9. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026